OASIS 5 Study Design NSTE ACS patients 2 of 3: Age > 60, ECG, Markers N=20,000 NSTE ACS patients 2 of 3: Age > 60, ECG, Markers N=20,000 Fondaparinux 2.5 mg SC QD Enoxaparin 1 mg/kg SC BID Death-MI-ischemia at 9d Major bleeding* at 9d Death-MI-ischemia at 9d Major bleeding* at 9d *ICH, RP, IO, Transfusion, Hgb 3 gm/dl
{}